|
China Pharma Holdings, Inc. (CHPI) |
|
|
|
CHPI's Net Cash Flow Growth by Quarter and Year
China Pharma Holdings,'s Net Cash Flow results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
Net Cash Flow Growth Y/Y▼
|
Net Cash Flow Growth Y/Y▼
|
CHPI Net Cash Flow (in millions $) |
FY 2015 |
FY 2014 |
FY 2013 |
FY 2012 |
IV Quarter |
December |
-
|
0.87
|
0.00
|
0.00
|
III Quarter |
September |
-
|
0.95
|
0.00
|
0.00
|
II Quarter |
June |
-
|
0.00
|
0.00
|
0.00
|
I Quarter |
March |
3.32
|
0.00
|
0.00
|
0.00
|
FY |
|
3.32
|
1.82
|
0.00
|
0.00
|
CHPI Net Cash Flow first quarter 2015 Y/Y Growth Comment |
China Pharma Holdings, Inc. in the first quarter 2015 achieved Net Cash Flow of $ 3.32 millions compare to net cash outflow recorded in same quarter a year ago.
Looking into first quarter 2015 results within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Cash Flow growth. While China Pharma Holdings, Inc.' s Net Cash Flow no change of % ranks overall at the positon no. 257 in the first quarter 2015.
|
CHPI Net Cash Flow ( Y/Y Growth %) |
2015
|
2014 |
2013 |
2012 |
IV Quarter |
December |
- |
- |
- |
- |
III Quarter |
September |
- |
- |
- |
- |
II Quarter |
June |
- |
- |
- |
- |
I Quarter |
March |
- |
- |
- |
- |
FY |
|
- |
- |
- |
- |
CHPI Net Cash Flow (Quarter on Quarter Growth %) |
2015
|
2014 |
2013 |
2012 |
IV Quarter |
December |
- |
-8.42 % |
- |
- |
III Quarter |
September |
- |
- |
- |
- |
II Quarter |
June |
- |
- |
- |
- |
I Quarter |
March |
281.73 % |
- |
- |
- |
FY (Year on Year) |
|
- |
- |
- |
- |
Net Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
-9.35 % |
-9.35 % |
-9.35 % |
(Sep 30 2011) |
|
|
|
Net Cash Flow Y/Y Growth Statistics |
High |
Average |
Low |
-9.35 % |
-9.35 % |
-9.35 % |
(Sep 30 2011) |
|
|
|
Net Cash Flow by Quarter for the Fiscal Years 2012, 2013, 2014, 2015 |
China Pharma Holdings,'s Q/Q Net Cash Flow Growth
Net Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
-9.35 % |
-9.35 % |
-9.35 % |
(Sep 30 2011) |
|
|
CHPI's I. Quarter Q/Q Net Cash Flow Comment |
China Pharma Holdings, Inc. achieved in the I. Quarter 2015 above company average sequential Net Cash Flow doubling of 281.73%, to $ 3.32 millions, from $0.87 millions in the fourth quarter. China Pharma Holdings, is undergoing a remarkable growth, not just reporting above average growth, and also improving pace, Alejandro Díaz, a business insider mentioned.
Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Cash Flow quarter on quarter growth. While China Pharma Holdings,'s Net Cash Flow growth quarter on quarter, overall rank is 257. |
|
|
Net Cash Flow Q/Q Growth Statistics |
High |
Average |
Low |
-9.35 % |
-9.35 % |
-9.35 % |
(Sep 30 2011) |
|
|
CHPI's I. Quarter Q/Q Net Cash Flow Comment |
China Pharma Holdings, Inc. achieved in the I. Quarter 2015 above company average sequential Net Cash Flow doubling of 281.73%, to $ 3.32 millions, from $0.87 millions in the fourth quarter. China Pharma Holdings, is impressively improving, not only recording above regular growth, and also improving pace.
Within Major Pharmaceutical Preparations industry 19 other companies have achieved higher Net Cash Flow quarter on quarter growth. While China Pharma Holdings,'s Net Cash Flow growth quarter on quarter, overall rank is 257. |
|
China Pharma Holdings,'s 12 Months Net Cash Flow Growth Year on Year
Net Cash Flow TTM Growth |
12 Months Ending (Mar 31 2012) |
12 Months Ending (Sep 30 2011) |
12 Months Ending (Jun 30 2011) |
12 Months Ending |
12 Months Ending |
Cumulative Net Cash Flow 12 Months Ending |
$ 0.00 |
$ 0.00 |
$ 0.00 |
$ 0.00 |
$ 0.00 |
Y / Y Net Cash Flow Growth (TTM) |
- |
- |
- |
- |
- |
Year on Year Net Cash Flow Growth Overall
Ranking |
# |
# |
# |
# |
# |
Seqeuential Net Cash Flow Change (TTM) |
- |
- |
- |
- |
- |
Seq. Net Cash Flow Growth (TTM) Overall
Ranking |
# |
# |
# |
# |
# |
Cumulative Net Cash Flow growth
Comment |
In the Mar 31 2012 period, China Pharma Holdings,'s cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.
China Pharma Holdings, Inc. achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. . |
Net Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
|
|
Net Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
Net Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# |
Sector |
# |
S&P 500 |
# |
|
Cumulative Net Cash Flow growth
Comment |
In the Mar 31 2012 period, China Pharma Holdings,'s cumulative trailing twelve month Net Cash Flow remained unchanged compare to the same period a year ago.
China Pharma Holdings, Inc. achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. . |
Net Cash Flow TTM Q/Q Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
Net Cash Flow TTM Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
Net Cash Flow TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# |
Sector |
# |
S&P 500 |
# |
|